Related Experiment Video
Updated: Jun 25, 2026
07:15
Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
Published on: January 16, 2019
Sudden cardiac death: The larger problem... The larger genome
1Division of Cardiology, Department of Medicine, Johns Hopkins School of Medicine, Baltimore, Maryland 21287, USA. pspoone1@jhmi.edu
Journal of Cardiovascular Electrophysiology
|February 12, 2009
Summary
Genetic factors increase the risk of lethal ventricular arrhythmias in the general population, not just rare inherited conditions. Understanding these genetic influences is key to preventing sudden cardiac death.
Area of Science:
- Cardiovascular Genetics
- Molecular Cardiology
- Genomics
Background:
- Genetic factors play a role in lethal ventricular arrhythmias.
- Distinguishing common genetic influences from rare inherited conditions like Long-QT and Brugada syndromes is crucial.
- Understanding the genetic basis of sudden cardiac death is an ongoing challenge.
Purpose of the Study:
- To review the current understanding of genetic influences on lethal ventricular arrhythmias in the general population.
- To explore unresolved issues regarding the significance and mechanisms of these genetic effects.
- To discuss novel genomic mechanisms and the identification of susceptibility genes for sudden death prevention.
Main Methods:
- Perspective review of existing literature.
- Analysis of genetic and genomic findings related to arrhythmias.
- Discussion of potential mediators and pathways.
Main Results:
- Genetic influences on ventricular arrhythmias extend beyond rare inherited syndromes.
- New mechanisms of genomic function are being uncovered.
- Identifying specific susceptibility genes and pathways remains a significant challenge.
Conclusions:
- Genetic predisposition to lethal ventricular arrhythmias is a complex issue in the broader population.
- Further research into genetic mediators and pathways is needed.
- Identifying novel genetic targets is essential for developing effective strategies to prevent sudden cardiac death.
More Related Videos
Related Concept Videos
01:11Genome-wide Association Studies-GWAS
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
01:30Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
01:30Coronary Artery Disease III: Clinical Manifestations
Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
03:21Genome Size and the Evolution of New Genes
While every living organism has a genome of some kind (be it RNA, or DNA), there is considerable variation in the sizes of these blueprints. One major factor that impacts genome size is whether the organism is prokaryotic or eukaryotic. In prokaryotes, the genome contains little to no non-coding sequence, such that genes are tightly clustered in groups or operons sequentially along the chromosome. Conversely, the genes in eukaryotes are punctuated by long stretches of non-coding sequence.
03:21Genome Size and the Evolution of New Genes
While every living organism has a genome of some kind (be it RNA, or DNA), there is considerable variation in the sizes of these blueprints. One major factor that impacts genome size is whether the organism is prokaryotic or eukaryotic. In prokaryotes, the genome contains little to no non-coding sequence, such that genes are tightly clustered in groups or operons sequentially along the chromosome. Conversely, the genes in eukaryotes are punctuated by long stretches of non-coding sequence.